The Japanese government is planning to start the easing of regulations in 2014 to connect research results of university hospitals to development of new medicines for intractable diseases, e.g. Alzheimer’s disease. 15 hospitals including the University of Tokyo hospital will be designated hospitals and the research results of these hospitals can be used to cut experimenting to save five years of drug development time. This will be one of the practical actions of the Prime Minister Abe’s growth strategy in medical sector.
If the amendment gets approved, this change would be applicable from 2014. Pharmaceutical companies may use the research results for the drug development directly with this system. The 15 hospitals include University of Tokyo hospital, University of Kyoto hospital, University of Osaka hospital, Keio University hospital, National Cancer Research Institute and only hospitals with capability to perform advanced research results and credibility to operate transparent collaboration with companies can be selected. Already ten hospitals are selected and five more hospitals will be selected by public call. The research results will be evaluated regularly and hospitals will be changed accordingly.
Source: Nikkei Newspaper Feb 27, 2013